NEWSROOM

medical

Odyssey Health, Inc. Announces Positive Results from Its Phase I Multi-Day Ascending Dosing for the Treatment of Concussion

  Las Vegas, NV, August 10, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, a company focused on developing unique, life-improving medical products, today announces the completion and safety findings from Cohort I of its Multi-Day Ascending Dosing (MAD) arm for its Phase I Clinical Trial. Odyssey’s trial is administering PRV-002, its novel drug to treat concussion, to healthy human subjects. MAD Cohort I subjects were dosed for five...

read more

Odyssey Health, Inc. Launches New Corporate Website

  Las Vegas, NV, August 04, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, a company focused on developing unique, life-saving medical products, is pleased to announce the launch of its new innovative corporate website: https://www.odysseyhealthinc.com/. The new corporate website, like the Company’s previously announced name change, was designed to not only better reflect Odyssey Health’s mission and focus, but also improve communication...

read more

RemSleep Holdings Inc. Commences Trading on OTCQB

    Tampa, FL, July 27, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever improving the level of treatment provided to obstructive Sleep Apnea patients, is pleased to announce that the company’s common shares will begin trading on the OTCQB Market as of the opening of the market on today, July 27, 2022. The OTCQB is the premiere marketplace for entrepreneurial and development stage U.S. and international companies that...

read more

RemSleep Holdings Inc. Engages New Senior Director for Regulatory Compliance and New Regulatory Testing Company Self Service Press Release

  Tampa, FL, July 22, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever improving the level of treatment provided to obstructive Sleep Apnea patients, announces the company has formally retained a new Senior Director for Regulatory Compliance and Regulatory submissions to gain FDA clearance to market the company’s medical device respiratory products. In addition, a new Regulatory Testing Company has been engaged.  Both will...

read more

Institute of Biomedical Research Corp Announces Purchase of Biomedical and Nutraceutical Assets

  SEATTLE, WA, July 22, 2022 -- McapMediaWire -- Institute of Biomedical Research Corp. (OTC Pink: MRES), a diversified biomedical company, announces the purchase of biomedical and nutraceutical assets from Wuhan General Group (China), Inc in an all-cash-transaction ("Purchase''). "This purchase is a perfect match to our business model and supports both our strategy in this sector and our direction to continue to create  a path for success for our shareholders," said Kim Halvorson,...

read more

Human Unitec International Launches Web3, Metaverse, and Blockchain based Real Estate Investment Opportunities via Tokenization of Luxury Real Estate Properties, Services, and Amenities

  Flagship Opportunities Open in Breathtaking Mediterranean Island of Sardinia, Italy   Champlain, New York, July 20, 2022 - McapMediaWire - Human Unitec International, Inc. (OTC Pink: HMNU) (“Human Unitec" “HMNU”, or the "Company") announces that on July 25, 2022, it will launch its BCPE (BlockChain Property Enterprises), a tokenization of global real estate opportunities around the world, beginning with its flagship offerings on the beautiful Mediterranean island of Sardinia, Italy...

read more

RemSleep Holdings Inc. Issues Correction to July 12th, 2022 Press Release

  Tampa, FL, July 19, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive Sleep Apnea patients, provides today, an update to the Company’s press release entitled, “RemSleep Holdings Inc. Announces Acceptance and Approval of the Company’s OTCQB Application” which was issued on July 12th, 2022. In said press release, RemSleep stated, “…announced today that the company has...

read more

RemSleep Holdings Inc. Announces Acceptance and Approval of the Company’s OTCQB Application

  Tampa, FL, July 12, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive Sleep Apnea patients, announced today that the company has officially received approval to be uplisted to OTCQB® status with otcmarkets.com. We anticipate OTCQB® status to be live on otcmarkets.com within 24-48 hours of this press release. The move to the OTCQB® exchange provides enhanced investor...

read more

Odyssey Health, Inc. Successfully Completes Phase I Single Ascending Dosing for Intranasal Concussion Drug

  Las Vegas, NV, July 12, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, a company focused on developing unique, life-enhancing medical products, today announced the completion of all three cohorts in their Phase I Single Ascending Dosing (SAD) clinical trial. Odyssey’s trial involves administering PRV-002, the Company’s novel drug to treat concussion, to healthy human subjects. For SAD, the drug was safe and well tolerated. Concussions...

read more

HUMAN UNITEC INTERNATIONAL ANNOUNCES AGREEMENT WITH MEDICAL CLINICS FOR ITS MEDICAL EQUIPMENT AND AN EXCLUSIVE MARKETING AGREEMENT WITH CESANA MEDIA CHINA

    Boston, Massachusetts, July 06, 2022 - McapMediaWire - Human Unitec International, Inc., (OTC Pink: HMNU) (“HMNU”), is a Project Finance, Management & Development for Sustainability, Medical, Wellness, and Green Energy provides July 6, 2022 Corporate Status Update. ​​​​​​​​​​​Human Unitec is proud to announce the appointment of Cesana Media China, http://www.cesanamedia.cn/en/, as the exclusive marketing agent for the HMNU Medical Equipments and HMNU Medical Centers, The...

read more

Odyssey Health, Inc. Completes Safety Evaluation of Cohort II for Concussion Drug

  Las Vegas, NV, June 29, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, a company focused on developing unique, life-saving medical products, today announced positive safety findings from Cohort II of their Phase I clinical trial. Odyssey’s trial involves administering PRV-002, the Company’s novel drug to treat concussion, to healthy human subjects. Data from Cohort II indicates that the drug was safe and well-tolerated. The trial is...

read more

HUMAN UNITEC INTERNATIONAL ANNOUNCES IT’S SUPPORT TO MSK KINESIS FOUNDATION FOR ITS 2022 HUMANITARIAN MISSION IN AFRICAN NATION GAMBIA

    Boston, Massachusetts, June 22, 2021 - McapMediaWire - Human Unitec International, Inc., (OTC Pink: HMNU) (“HMNU”), is a Project Finance, Management & Development for Sustainability, Medical, Wellness, and Green Energy provides Corporate Status Update. ​​​​​​​​​​​On June 6, 2022, during a meeting headed at Gambia Consulate in Milano, Italy, Professor Francesco Cristina di Santannera, Counsellor of Gambia and the Msk Kinesis Foundation Representatives finalized the program for...

read more

RemSleep Holdings Inc Addresses Shareholders

  Tampa, FL, June 16, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, would like to address shareholders regarding the S-1 filing from June 15th, 2022. First and foremost, we want to be clear, we did not file the S-1 out of necessity. This was set up as a precautionary safety net given the current global and U.S. economic dynamics, and the...

read more

RemSleep Holdings Inc. Submits Application For Uplisting to OTCQB

  Tampa, FL, June 10, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, today announced that the company has officially filed its application for OTCQB® status with otcmarkets.com. The company anticipates receiving a decision on the application in approximately 3-4 weeks. The Company believes that the move to the OTCQB® will provide enhanced...

read more

RedChip Interviews Odyssey Health, Inc.’s CEO Michael Redmond

  Las Vegas, NV, June 08, 2022 -- McapMediaWire -- RedChip Companies will air a new C-Level interview with Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International on The RedChip Money Report® on Bloomberg TV, this Saturday, June 11, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the US. RedChip’s CEO Dave Gentry interviews Odyssey’s CEO Michael Redmond in this exclusive interview, covering the questions on the mind of...

read more

RemSleep Holdings Inc. Issues a Letter from the CEO

  Tampa, FL, June 06, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, today provides a corporate update and letter from CEO Tom Wood. Dear Shareholders, On Friday the 27th of May, we were informed by the FDA after months of waiting, the DeltaWave will be reclassified under 510K review as an implantable device. Consequently, additional testing is...

read more

Odyssey Health, Inc. Completes Safety Evaluation of Cohort I for Concussion Drug

  IRVINE, CA, June 01, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, a company focused on developing unique, life-saving medical products, today announced positive safety findings from Cohort I of their Phase I clinical trial. Odyssey’s trial involves administering PRV-002, the Company’s novel drug to treat concussion, to healthy human subjects. For Cohort I, the drug was safe and well tolerated. Concussions represent an ‘unmet’ medical...

read more

RemSleep Holdings Inc. Announces 510(k) Submission for DeltaWave

  Tampa, FL, May 6, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, today announced that the company has responded to the Additional Information request pertaining to their current 510(k) application to the U.S. Food and Drug Administration (FDA) for its patented DeltaWave device, a nasal mask CPAP interface. https://youtu.be/6Dtl4485Yn8 “This...

read more

Odyssey Health, Inc. Announces Positive Results from Initial Phase I Clinical Trial Subjects for Concussion Drug

  IRVINE, CA, May 5, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, a company focused on developing unique, life-saving medical products, today announced positive results from the first group of patients dosed with PRV-002, in their Phase I clinical trial. Odyssey’s trial is administering PRV-002, their novel drug to treat concussion, to healthy human subjects. Thus far the drug has shown to be safe and well tolerated. Each year, there...

read more

Odyssey Health Welcomes United States Vice Admiral (r) Timothy Szymanski to Military Advisory Board

  IRVINE, CA, April 20, 2022 -- McapMediaWire -- Odyssey Health, Inc., formerly known as Odyssey Group International, Inc. (OTC Pink: ODYY) (the "Company" or "Odyssey"), a company focused on developing a proprietary drug compound to treat concussion, is honored to welcome Vice Admiral (r) Timothy Szymanski to the Company’s prestigious Military Advisory Board. Odyssey’s drug candidate, PRV-002 is currently in a phase 1 clinical trial. “Too many service members and veterans are suffering...

read more

Odyssey Group International Announces Formation of Military Advisory Board and Welcomes Prestigious Members to Assist with Concussion Drug Development

  IRVINE, CA, March 31, 2022 -- McapMediaWire -- Odyssey Group International, Inc. (OTC Pink: ODYY) (the "Company" or "Odyssey"), a company focused on developing unique, life-saving medical products, today announced the formation of its Military Advisory Board with the appointment of prestigious leaders in the field. Garnering experience and insight from these leaders in our military service branches will provide critical insight to traumatic brain injuries and the effects it has on those...

read more

RemSleep Holdings Inc. Provides a Shareholder Update

  Tampa, FL, March 28, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, provides a corporate update to the company’s shareholders. When submitting a 510k for a device such as the DeltaWave, there are a myriad of tests that need to be carried out to prove to the FDA that the device is safe and effective. The company has diligently carried out...

read more

RemSleep Holdings Announces Significant Distribution Agreement for Nasal CPAP Machines to Address USA CPAP Shortage

  Tampa, FL, March 22, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, is excited to announce that the company has recently negotiated an agreement with an overseas manufacturer for the import of nasal CPAP machines. The initial order of 1500 units has been placed and the shipment of nasal CPAP devices will be expected to occur in mid-April,...

read more

HealthPoint Plus Launches V3.0 of Their Comprehensive Subscription-Based Telehealth Platform

    The latest release adds expanded Primary Care support, Behavioral Health, and even Pet Telehealth to its already expansive Urgent Care service Danvers, Massachusetts, March 10, 2022  -- McapMediaWire -- HealthPoint Plus Inc, a disruptive subscription-based Telehealth medical company who recently signed a LOI to merge with Stargaze Entertainment Group, Inc. (OTC Pink: STGZ), announces the release of HealthPoint Plus Version 3.0, a disruptive Subscription-Based Telehealth Platform....

read more

Stargaze Entertainment Announces Letter of Intent to Merge with HealthPoint Plus, Inc.

    Stargaze Entertainment Group, Inc. has Signed a Letter of Intent to merge with HealthPoint Plus, Inc., a subscription-based Telemedicine company   PLATSBURGH, NEW YORK, Feb. 08, 2022 -- McapMediaWire -- Stargaze Entertainment Group, Inc. (OTC Pink: STGZ) today announced the signing of a letter of intent to merge with HealthPoint Plus Inc, a disruptive subscription-based Telehealth medical company. According to Precedence Research, the global telehealth market size is...

read more

RemSleep Holdings Inc Announces Engagement of New Investor Relations Firm and News Distributor

  Tampa, FL, Jan. 24, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, is proud to announce that we have partnered with Preya Co and MCAP Mediawire to maximize our communication and exposure with current and potential shareholders in conjunction with refining and broadening our overall messaging and outreach. This is in anticipation and because...

read more

Xcelerate, Inc. Issues Shareholder Update

  Mauldin, SC, Jan. 12, 2022 -- McapMediaWire -- Xcelerate, Inc. (OTC PINK: XCRT) Mike O’Shea, CEO, today released a shareholder update. 2021 has proven to be a formative year for Xcelerate during which we achieved reporting status with OTC Markets, began trading under our current symbol, introduced our corporate website, completed audits of consolidated financial statements for 2019 and 2020, signed investment banking and consulting agreements to assist in sourcing capital and, most...

read more

Odyssey Group International Receives Donation to Support a Treatment for Concussion and forms Community Partnership with the Erase PTSD Now Foundation

  IRVINE, CA, Jan. 10, 2022 -- McapMediaWire -- Odyssey Group International, Inc. (OTC Pink: ODYY) (the "Company" or "Odyssey"), a company focused on developing unique, life-saving medical products, today announced that it has received a donation in the amount of $500,000 in partnership with the Erase PTSD Now organization and the Glenn Greenberg and Linda Vester Foundation. These funds will be used to progress the Phase 1 human clinical trials for drug candidate PRV-002 for the treatment...

read more

AVRA Medical Robotics, Inc. Appoints Dr Doga Demirel to its Surgical Robotic System Team

    ORLANDO, FL, Dec. 21, 2021 -- McapMediaWire -- AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTC: AVMR) today announces the appointment of Dr. Doga Demirel, a leading expert in computer science, particularly as it applies to surgical procedures ranging from airways through the minimization of invasive procedures for joints and bones, to pancreatic cancer, as Senior Design Scientist to join the AVRA team and assist in the development of its advanced surgical robotic...

read more

The Different Types of Medical Equipment and How It’s Useful

  London, UK, December 20, 2021 - McapMediaWire - Medical equipment is a broad term that can refer to anything from wheelchairs to CT scanners. While the different types of medical equipment can serve other purposes, they're all essential in helping healthcare professionals provide quality care to their patients. Here's a look at some of the most common types of medical equipment. Laboratory Equipment Medical laboratory equipment performs lab tests on samples from patients, so doctors can...

read more

Categories

Mcap MediaWire - Costumer Service

Translate »